Announcements Trials
Browse Landscape

Phase

Phase 2 135Phase 1 119Phase 1/2 85Phase 3 45Phase EARLY_PHASE1 16Phase 2/3 7Phase 4 3Phase NA 2

Status

Completed 48Unknown 23Terminated 15Withdrawn 9Not yet recruiting 4Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Mesothelin-positive Advanced Malignant Solid Tumors 1Leukemia, Myeloid, Acute 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Cyclophosphamide × Clear all
NCT07588360 2026-05-14

Haplo-Cord HSCT for AML/MDS

Fujian Medical University Union Hospital

Phase NA Recruiting
180 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07010523 2025-06-08

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Zhejiang University

Phase NA Recruiting
24 enrolled
Other solid neoplasm

Mesothelin-positive Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡